Lead sponsor
Solvay Pharmaceuticals
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
60
Total enrollment
46
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
1
Trials by status
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's TypeAlzheimer's diseasePh 3Terminated60